Top Markets
#1 ADO Protocol ADO Protocol +336.92%
#2 GoPlus Security GoPlus Security +51.52%
#3 Starpower Starpower +34.81%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.35%
#5 GAIB AID GAIB AID +24.67%
#6 Nockchain Nockchain +22.29%
#7 Tutorial Tutorial +20.42%
#8 Fake World Assets Fake World Assets +18.96%
#9 The Black Bull The Black Bull +18.07%
#10 OpenEden OpenEden +14.61%
Coin of the day
ADO Protocol ADO Protocol
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

CTXR
Rankning i aktier #34065
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm... Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Aktiekurs
$0.5682
Marknadsvärde
$6.35M
Förändring (1 dag)
-24.80%
Förändring (1 år)
-57.28%
Land
US
Handel Citius Pharmaceuticals, Inc. (CTXR)

Kategori

Healthcare
Aktiekurshistorik för Citius Pharmaceuticals, Inc. (CTXR)
Högsta slutkurs: $0.69 den 2026-08-01

Lägsta slutkurs: $374.99 den 2014-10-01
Aktiekurshistorik för Citius Pharmaceuticals, Inc. från 2014 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -13.63%
2025 -66.66%
2024 -83.96%
2023 -24.36%
2022 -35.96%
2021 48.68%
2020 66.19%
2019 -38.70%
2018 -76.18%
2017 -33.16%
2016 -74.07%
2015 50.02%
2014 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $513.44 30.72%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $997.96 52.63%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.90 7.23%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.97 13.59%
BE